Santen Pharmaceutical Co (JP:4536) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Santen Pharmaceutical Co. has successfully repurchased 3,729,200 common shares totaling over 6.29 billion yen as part of its share buyback program implemented in November 2024. The buyback is a strategic move to enhance shareholder value, with a maximum target of 5 million shares and a budget of 10 billion yen set by the company.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
